NUWELLIS, INC. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
NUWELLIS, INC. (NUWE) had Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 1.33% as of 2016-11-03, per its 10-K filed 2018-03-22.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2018-03-22
- 2016-11-03: Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 1.33%.
- 2016-07-26: Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 0.94%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) |
|---|---|
| 2016-11-03 | 1.33% 10-K · filed 2018-03-22 |
| 2016-07-26 | 0.94% 10-K · filed 2018-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |